Gain Therapeutics, Inc. (GANX)
NASDAQ·Healthcare·Biotechnology
$1.03
+0.00%
Mkt Cap $43.93M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (6 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+385.4%
Consensus $5.00 vs current $1.03
NASDAQ·Healthcare·Biotechnology
$1.03
+0.00%
Mkt Cap $43.93M
Buy
5
Hold
0
Sell
0
Price Target (6 analysts)
$5.00
Range $5.00 – $5.00
+385.4%
Consensus $5.00 vs current $1.03